DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Messing EM, Manola J, Wilding G, Propert K, Fleischmann J, Crawford ED, Pontes JE, Hahn R, Trump D.
Phase III study of interferon alfa-NL as adjuvant treatment
for resectable renal cell carcinoma: an Eastern Cooperative Oncology
Group/Intergroup trial.
J Clin Oncol 2003; 21: 1214-1222
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.